Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease

CMAJ. Canadian Medical Association Journal

Volumn 184, Issue 9, 2012, Pages

  Rocker, Graeme ^a   Young, Joanne ^a   Donahue, Margaret ^a   Farquhar, Morag ^b   Simpson, Catherine ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MORPHINE SULFATE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ANXIETY; ARTICLE; CANADA; CAREGIVER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONSTIPATION; DEPRESSION; DRUG EFFECT; DRUG USE; DYSPNEA; FAMILY ATTITUDE; FEAR; FEMALE; HUMAN; LEGAL ASPECT; LIBIDO DISORDER; MALE; PATIENT ATTITUDE; PERSONAL EXPERIENCE; PHYSICIAN ATTITUDE; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; PRURITUS; QUALITATIVE RESEARCH; QUALITY OF LIFE; SEMI STRUCTURED INTERVIEW; SIDE EFFECT; STRESS; SWEATING; XEROSTOMIA;

EID: 84862117795     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.111758     Document Type: Article

References (40)

1. Gershon AS, Wang C, Wilton AS, et al. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med 2010;170:560-5.
2. Elkington H, White P, Addington-Hall J, et al. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med 2005;19:485-91. (Pubitemid 41430822)
3. Rocker GM, Dodek PM, Heyland DK. Toward optimal end-of-life care for patients with advanced chronic obstructive pulmonary disease: Insights from a multicentre study. Can Respir J 2008;15:249-54.
4. Heyland DK, Dodek P, Rocker G, et al. What matters most in end-of-life care: perceptions of seriously ill patients and their family members. CMAJ 2006;174:627-33. (Pubitemid 43341872)
5. Heyland DK, Cook DJ, Rocker GM, et al. Defining priorities for improving end-of-life care in Canada. CMAJ 2010;182:E747-52.
6. Rocker G, Horton R, Currow D, et al. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids. Thorax 2009;64:910-5.
7. Marciniuk DD, Goodridge D, Hernandez P, et al.; Canadian Thoracic Society COPD Committee Dyspnea Expert Working Group. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline. Can Respir J 2011;18:69-78.
8. Rocker GM, Young J, Horton R. Using opioids to treat dyspnea in advanced COPD: A survey of Canadian clinicians. http://meeting.chestpubs.org/cgi/content/ abstract/134/4/s29001. 2008. (accessed 2012 Mar. 21).
9. Young J, Donahue M, Simpson AC, et al. Attitudes to using opioids to treat dyspnea in advanced copd: a qualitative study of family physicians and respiratory therapists. Can Fam Physician. In press.
10. O'Cathain A, Murphy E, Nicholl J. Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study. BMC Health Serv Res 2007;7:85.
11. Bausewein C, Farquhar M, Booth S, et al. Measurement of breathlessness in advanced disease: a systematic review. Respir Med 2007;101:399-410. (Pubitemid 46205909)
12. Rocker G. Dyspnea: recent insights and innovations. Prog Palliat Care. 2011;19:219-22.
13. Farquhar MC, Ewing G, Booth S. Using mixed methods to develop and evaluate complex interventions in palliative care research. Palliat Med 2011;25:748-57.
14. Strauss A, Corbin J. Basics of qualitative research. techniques and procedures for developing grounded theory. 2nd ed. London (UK): Sage publications; 1998.
15. Puhan MA, Guyatt GH, Goldstein R, et al. Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respir Med 2007;101:308-16. (Pubitemid 46075963)
16. Anderson F, Downing GM, Hill J, et al. Palliative performance scale (PPS): a new tool. J Palliat Care 1996;12:5-11. (Pubitemid 126672217)
17. Dowson C, Laing R, Barraclough R, et al. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J 2001;114:447-9. (Pubitemid 32982731)
18. Cohen SR, Mount BM, Strobel MG, et al. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 1995;9:207-19.
19. Cohen R, Leis AM, Kuhl D, et al. QOLLTI-F: measuring family carer quality of life. Palliat Med 2006;20:755-67. (Pubitemid 46040127)
20. Smith HS. The Numerical Opioid Side Effect (NOSE) assessment tool. J Cancer Pain Symptom Palliation 2006;1:3-6. (Pubitemid 44181052)
21. Thorne S, Con A, McGuinness L, et al. Health care communication issues in multiple sclerosis: an interpretive description. Qual Health Res 2004;14:5-22. (Pubitemid 44534598)
22. Thorne S. Interpretive description. Walnut Creek (CA): Left Coast Press Inc.; 2008. p. 272.
23. Booth S, Farquhar M, Gysels M, et al. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea:A qualitative phase 1 study. Palliat Support Care 2006;4:287-93.
24. Simpson AC, Young J, Donahue M, et al. A day at a time: caregiving on the edge in advanced COPD. Int J Chron Obstruct Pulmon Dis 2010;5:141-51.
25. O'Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J 2008;15(Suppl A):1A-8A. (Pubitemid 351566057)
26. Simpson AC, Rocker GM. Advanced chronic obstructive pulmonary disease: impact on informal caregivers. J Palliat Care 2008;24:49-54.
27. Lanken PN, Terry PB, Delisser HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 2008;177:912-27. (Pubitemid 351600670)
28. Mahler DA, Selecky PA, Harrod CG, et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest 2010;137:674-91.
29. Oxberry SG, Jones L, Clark AL, et al. Attitudes to morphine in chronic heart failure patients. BMJ Support Palliat Care 2011 Dec. 13 [epub ahead of print].
30. Zerzan J, Lee CA, Haverhals LM, et al. Exploring physician decisions about end- of-life opiate prescribing: a qualitative study. J Palliat Med 2011;14:567-72.
31. Spitz A, Moore AA, Papaleontiou M, et al. Primary care providers' perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative study. BMC Geriatr 2011;11:35.
32. Goodridge D, Lawson J, Rocker G, et al. Factors associated with opioid dispensation for patients with COPD and lung cancer in the last year of life: A retrospective analysis. Int J Chron Obstruct Pulmon Dis 2010;5:99-105.
33. Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002;57:939-44. (Pubitemid 35316271)
34. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327:523-8.
35. Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage 2011;42:388-99.
36. Rocker G, Demmons J, Donahue M, et al. Using opioids to treat refractory dyspnea in advanced COPD: preliminary insights from a clinical trial. Chest 2011;140:543A. Available: http://chestjournal.chestpubs.org/cgi/content/meeting- abstract/140/4-MeetingAbstracts/543A (accessed 2012 Mar. 26).
37. Lynn J, Nolan K, Kabcenell A, et al. Reforming care for persons near the end of life: the promise of quality improvement. Ann Intern Med 2002;137:117-22. (Pubitemid 34779155)
38. Kamal AH, Miriovsky BJ, Currow DC, et al. Improving the management of dyspnea in the community using rapid learning approaches. Chron Respir Dis. In press.
39. Code of ethics of the Canadian Medical Association. CMAJ 1996;155:1063-5.
40. Gallagher R. Killing the symptom without killing the patient. Can Fam Physician 2010;56(6):544-546, e210-512.